The future of TMB in cancer research looks promising, with ongoing studies aiming to refine its predictive accuracy and integrate it with other biomarkers. Advances in bioinformatics and sequencing technologies are expected to improve the precision of TMB assessment. Additionally, research is focused on understanding the biological mechanisms behind TMB and its role in shaping the tumor microenvironment.